Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 5 results.
User Information
Export Records
  1. 1.   The SRC family kinase inhibitor NXP900 demonstrates potent anti-tumor activity in squamous cell carcinomas
  2. Dash,Sweta; Hanson, Sabrina; King, Ben; Nyswaner, Katherine; Foss, Kelcie; Tesi,Noelle; Harvey, Mungo J B; Navarro-Marchal, Saúl A; Woods, Allison; Poradosu, Enrique; Unciti-Broceta, Asier; Carragher, Neil O; Brognard,John
  3. The Journal of Biological Chemistry. 2024, Jul 30; 107615.
  1. 2.   Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
  2. Logue, J. S.; Morrison, D. K.
  3. Genes & Development. 2012, Apr; 26(7): 641-650.
  1. 3.   Phosphatidylinositol 3 '-kinase is required for growth of mast cells expressing the Kit catalytic domain mutant
  2. Shivakrupa, R.; Bernstein, A.; Watring, N.; Linnekin, D.
  3. Cancer Research. 2003 63(15): 4412-4419.
  1. 4.   Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant
  2. Chian, R. J.; Young, S.; Danilkovitch-Miagkova, A.; Ronnstr, L.; Leonard, E.; Ferrao, P.; Ashman, L.; Linnekin, D.
  3. Blood. 2001 98(5): 1365-1373.
  1. 5.   Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells
  2. O'Laughlin-Bunner, B.; Radosevic, N.; Taylor, M. L.; Shivakrupa, DeBerry, C.; Metcalfe, D. D.; Zhou, M. J.; Lowell, C.; Linnekin, D.
  3. Blood. 2001 98(2): 343-350.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel